INTEGRATED FILING — Other than Banks



General information about company

Scrip code 000000
NSE Symbol MAITREYA
MSEI Symbol NOTLISTED
ISIN INE0PLQ01011
Name of Company Maitreya Medicare Limited
Type of company SME
Class of security Equity
Date of start of financial year 01-Apr-2024
Date of end of financial year 31-Mar-2025
Date of board meeting when results were approved 30-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 23-May-2025
Description of presentation currency INR (in Actuals)
Reporting Type Half Yearly
Reporting Quarter Yearly
Nature of report standalone or consolidated Consolidated
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Single segment
Description of single segment Hospital
Start date and time of board meeting 30-May-2025   20:00:00
End date and time of board meeting 30-May-2025   20:40:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion


Financial Results — Other than Bank

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Oct-2024 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Consolidated Consolidated
Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1 Revenue From Operations
Revenue from operations 222992000 466620000
Other income 3962000 5860000
Total Income 226954000 472480000
2 Expenses
(a) Cost of materials consumed 12811000 28717000
(b) Purchases of stock-in-trade 32949000 59139000
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade -714000 -248000
(d) Employee benefit expense 34874000 63220000
(e) Finance costs 3511000 8020000
(f) Depreciation and amortisation expense 7811000 14421000
(g) Other Expenses
1 OTHER 126233000 267108000
Total other expenses 126233000 267108000
Total expenses 217475000 440377000
3 Profit before exceptional and extraordinary items and tax 9479000 32103000
4 Exceptional items 0 0
5 Profit before extraordinary items and tax 9479000 32103000
6 Extraordinary items 0 0
7 Profit before tax 9479000 32103000
8 Tax Expense
Current tax 7531000 13314000
Deferred tax -52000 65000
Total tax expenses 7479000 13379000
9 Net Profit Loss for the period from continuing operations 2000000 18724000
10 Profit (loss) from discontinuing operations before tax 0 0
11 Tax expense of discontinuing operations 0 0
12 Net profit (loss) from discontinuing operation after tax 0 0
13 Profit (loss) for period before minority interest 2000000 18724000
14 Share of profit (loss) of associates 0 0
15 Profit (loss) of minority interest 0 0
16 Net profit (Loss) for the period 2000000 18724000
17 Details of equity share capital
Paid-up equity share capital 67760000 67760000
Face value of equity share capital 10 10
18 Reserves excluding revaluation reserve 0
19 Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 0 0
Diluted earnings (loss) per share from continuing and discontinued operations 0 0
20 Debt equity ratio 0.0 0.0
21 Debt service coverage ratio 0.0 0.0
22 Interest service coverage ratio 0.0 0.0
23 Disclosure of notes on financial results


Remarks

20 Debt equity ratio
21 Debt service coverage ratio
22 Interest service coverage ratio


Cash flow statement — indirect

A Date of start of reporting period 01-Apr-2024
B Date of end of reporting period 31-Mar-2025
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Consolidated
1 Statement of cash flows
Cash flows from used in operating activities
Profit before extraordinary items and tax 32103000
2 Adjustments for reconcile profit (loss)
Adjustments to profit (loss)
Adjustments for finance costs 7984000
Adjustments for depreciation and amortisation expense 14421000
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0
Adjustments for unrealised foreign exchange losses gains 0
Adjustments for dividend income 0
Adjustments for share-based payments 0
Other adjustments for which cash effects are investing or financing cash flow 0
Other adjustments to reconcile profit (loss) 225000
Other adjustments for non-cash items 1675000
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0
Total adjustments to profit (loss) 24305000
3 Adjustments for working capital
Adjustments for decrease (increase) in inventories 147000
Adjustments for decrease (increase) in trade receivables -18444000
Adjustments for decrease (increase) in other current assets 222000
Adjustments for increase (decrease) in trade payables 6571000
Adjustments for increase (decrease) in other current liabilities 26432000
Adjustments for provisions -3918000
Total adjustments for working capital 11010000
Total adjustments for reconcile profit (loss) 35315000
Net cash flows from (used in) operations 67418000
Dividends received 0
Interest paid 0
Interest received -2154000
Income taxes paid (refund) 14695000
Other inflows (outflows) of cash 0
Net cash flows from (used in) operating activities before extraordinary items 50569000
Proceeds from extraordinary items 0
Payment for extraordinary items 0
Net cash flows from (used in) operating activities 50569000
4 Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0
Cash flows used in obtaining control of subsidiaries or other businesses 0
Other cash receipts from sales of equity or debt instruments of other entities 0
Other cash payments to acquire equity or debt instruments of other entities 0
Other cash receipts from sales of interests in joint ventures 0
Other cash payments to acquire interests in joint ventures 0
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0
Proceeds from sales of property plant and equipment -23813000
Purchase of property plant and equipment 0
Proceeds from sales of intangible assets 4300000
Purchase of intangible assets 44656000
Cash advances and loans made to other parties 11694000
Cash receipts from repayment of advances and loans made to other parties 0
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0
Dividends received 0
Interest received 2154000
Income taxes paid (refund) 0
Other inflows (outflows) of cash 0
Proceeds from government grants 0
Net cash flows from (used in) investing activities before extraordinary items -73709000
Proceeds from extraordinary items 0
Payment for extraordinary items 0
Net cash flows from (used in) investing activities -73709000
Cash flows from used in financing activities
Proceeds from issuing shares 51600000
Proceeds from issuing other equity instruments 0
Proceeds from issuing debentures notes bonds etc 0
Proceeds from borrowings 4783000
Repayments of borrowings 9665000
Dividends paid 0
Interest paid 7984000
Income taxes paid (refund) 0
Other inflows (outflows) of cash -2000000
Net cash flows from (used in) financing activities before extraordinary items 36734000
Proceeds from extraordinary items 0
Payment for extraordinary items 0
Net cash flows from (used in) financing activities 36734000
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes 13594000
6 Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0
Net increase (decrease) in cash and cash equivalents 13594000
Cash and cash equivalents cash flow statement at beginning of period 65569000
Cash and cash equivalents cash flow statement at end of period 79163000


Statement of Asset and Liabilities

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-Apr-2024
Date of end of reporting period 31-Mar-2025
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Consolidated
Equity and liabilities
1 Shareholders' funds
Share capital 121403000
Reserves and surplus 199428000
Money received against share warrants 0
Total shareholders' funds 320831000
2 Share application money pending allotment 0
3 Deferred government grants
4 Minority interest 7747000
5 Non-current liabilities
Long-term borrowings 36348000
Deferred tax liabilities (net) 7034000
Foreign currency monetary item translation difference liability account
Other long-term liabilities
Long-term provisions 0
Total non-current liabilities 43382000
6 Current liabilities
Short-term borrowings 15744000
Trade Payables
(A) Total outstanding dues of micro enterprises and small enterprises 3295000
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 28867000
Total Trade payable 32162000
Other current liabilities 51805000
Short-term provisions 8272000
Total current liabilities 107983000
Total equity and liabilities 479943000
Assets
1 Non-current assets
i Property, Plant and Equipment and Intangible assets
Property, Plant and Equipment 152597000
Producing properties
Intangible assets 0
Preproducing properties
Property, Plant and Equipment capital work-in-progress
Intangible assets under development or work-in-progress
Total Property, Plant and Equipment and Intangible assets 152597000
ii Non-current investments 10000
v Deferred tax assets (net)
vi Foreign currency monetary item translation difference asset account
vii Long-term loans and advances 30489000
viii Other non-current assets 18442000
Total non-current assets 201538000
Current assets
Current investments 422000
Inventories 5923000
Trade receivables 149565000
Cash and cash equivalents 79164000
Bank balance other than cash and cash equivalents 0
Short-term loans and advances 39789000
Other current assets 3542000
Total current assets 278405000
Total assets 479943000
Disclosure of notes on assets and liabilities


Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-Oct-2024 01-Apr-2024
Date of end of reporting period 31-Mar-2025 31-Mar-2025
Whether results are audited or unaudited Audited Audited
Nature of report standalone or consolidated Consolidated Consolidated
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets
Net Segment Asset
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities
Net Segment Liabilities
Disclosure of notes on segments




Details of Impact of Audit Qualification

Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 Saherwala & Co. Yes 31-Dec-2026